These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 32388673)

  • 1. Predictors of in-hospital mortality in patients with left ventricular assist device.
    Gonuguntla K; Patil S; Cowden RG; Kumar M; Rojulpote C; Bhattaru A; Tiu JG; Robinson P
    Ir J Med Sci; 2020 Nov; 189(4):1275-1281. PubMed ID: 32388673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A population based analysis of trends, risk factors and outcomes associated with gastrointestinal bleeding in patients with left ventricular assist devices.
    Gonuguntla K; Patil S; Rojulpote C; Cowden RG; Nasir M; Karambelkar P; Buch T; Aujla A; Bhattaru A; Borja ZE; Schulman P
    Am J Cardiovasc Dis; 2020; 10(3):247-257. PubMed ID: 32923107
    [No Abstract]   [Full Text] [Related]  

  • 3. Trends, Outcomes, and Predictors of Sepsis and Severe Sepsis in Patients with Left Ventricular Assist Devices.
    Gonuguntla K; Patil S; Gadela NV; Cowden R; Rojulpote C; Durugu S; Karambelkar P; Bhattaru A; Borja AJ; Zhang V
    Cureus; 2020 Apr; 12(4):e7523. PubMed ID: 32377471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex-Based Differences in Left Ventricular Assist Device Utilization: Insights From the Nationwide Inpatient Sample 2004 to 2016.
    Joshi AA; Lerman JB; Sajja AP; Dahiya G; Gokhale AV; Dey AK; Kyvernitakis A; Halbreiner MS; Bailey S; Alpert CM; Poornima IG; Murali S; Benza RL; Kanwar M; Raina A
    Circ Heart Fail; 2019 Sep; 12(9):e006082. PubMed ID: 31514517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National Trends in Utilization, Mortality, Complications, and Cost of Care After Left Ventricular Assist Device Implantation From 2005 to 2011.
    Shah N; Agarwal V; Patel N; Deshmukh A; Chothani A; Garg J; Badheka A; Martinez M; Islam N; Freudenberger R
    Ann Thorac Surg; 2016 Apr; 101(4):1477-84. PubMed ID: 26588867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender Differences in Outcomes After Implantation of Left Ventricular Assist Devices.
    Ahmed A; Adegbala O; Akintoye E; Inampudi C; Ajam M; Yassin AS; Olawusi E; Shokr M; Alvarez P; Briasoulis A
    Ann Thorac Surg; 2020 Mar; 109(3):780-786. PubMed ID: 31479642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Echocardiographic predictors of adverse outcomes after continuous left ventricular assist device implantation.
    Topilsky Y; Oh JK; Shah DK; Boilson BA; Schirger JA; Kushwaha SS; Pereira NL; Park SJ
    JACC Cardiovasc Imaging; 2011 Mar; 4(3):211-22. PubMed ID: 21414567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left Ventricular Assist Devices Impact Hospital Resource Utilization Without Affecting Patient Mortality in Gastrointestinal Bleeding.
    Li F; Hinton A; Chen A; Mehta NK; Eldika S; Zhang C; Hussan H; Conwell DL; Krishna SG
    Dig Dis Sci; 2017 Jan; 62(1):150-160. PubMed ID: 27858326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Impact of Diabetes Mellitus on Short-Term Outcomes andIn-Hospital Mortality of Cardiac Mechanical Support with Left Ventricular Assist Device (LVAD): A Retrospective Study from a National Database.
    Yassin AS; Subahi A; Adegbala O; Abubakar H; Akintoye E; Ahmed A; Ismail A; Elhag A; Kambal A; Alade A; Shokr M; Weinberger J; Levine D; Afonso L
    Cardiovasc Revasc Med; 2019 Oct; 20(10):883-886. PubMed ID: 30578171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of cardiac transplantation in patients requiring prolonged continuous-flow left ventricular assist device support.
    Takeda K; Takayama H; Kalesan B; Uriel N; Colombo PC; Jorde UP; Yuzefpolskaya M; Mancini DM; Naka Y
    J Heart Lung Transplant; 2015 Jan; 34(1):89-99. PubMed ID: 25444372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Trends, Mortality, and Readmissions After Insertion of Left Ventricular Assist Devices in Patients <65 Years Vs ≥65 Years.
    Rali AS; Ranka S; Acharya P; Buechler T; Weidling R; Mastoris I; Taduru S; Abicht T; Haglund N; Sauer AJ; Shah Z
    Am J Cardiol; 2020 Aug; 128():16-27. PubMed ID: 32650911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of peripheral arterial disease on left ventricular assist device implantation: A propensity-matched analysis of the nationwide inpatient sample database.
    Ullah W; Zahid S; Thalambedu N; Khan M; Massey H; Haas D; Tchantchaleishvili V; Rame E
    Artif Organs; 2021 Aug; 45(8):838-844. PubMed ID: 33559252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous-flow LVADs in the Nordic countries: complications and mortality and its predictors.
    Braun OÖ; Nilsson J; Gustafsson F; Dellgren G; Fiane AE; Lemström K; Hubbert L; Hellgren L; Lund LH
    Scand Cardiovasc J; 2019 Feb; 53(1):14-20. PubMed ID: 30776923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Annual Hospital Volume on Outcomes after Left Ventricular Assist Device (LVAD) Implantation in the Contemporary Era.
    Shah N; Chothani A; Agarwal V; Deshmukh A; Patel N; Garg J; Badheka A; Martinez M; Islam N; Freudenberger R
    J Card Fail; 2016 Mar; 22(3):232-7. PubMed ID: 26547012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in Utilization, Mortality, Major Complications, and Cost After Left Ventricular Assist Device Implantation in the United States (2009 to 2014).
    Briasoulis A; Inampudi C; Akintoye E; Adegbala O; Alvarez P; Bhama J
    Am J Cardiol; 2018 May; 121(10):1214-1218. PubMed ID: 29525059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and management of gastrointestinal bleeding with continuous flow assist devices.
    Aggarwal A; Pant R; Kumar S; Sharma P; Gallagher C; Tatooles AJ; Pappas PS; Bhat G
    Ann Thorac Surg; 2012 May; 93(5):1534-40. PubMed ID: 22541185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Use of Pediatric Ventricular Assist Devices in Children's Hospitals From 2000 to 2010: Morbidity, Mortality, and Hospital Charges.
    Mansfield RT; Lin KY; Zaoutis T; Mott AR; Mohamad Z; Luan X; Kaufman BD; Ravishankar C; Gaynor JW; Shaddy RE; Rossano JW
    Pediatr Crit Care Med; 2015 Jul; 16(6):522-8. PubMed ID: 25850863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era.
    Topkara VK; Kondareddy S; Malik F; Wang IW; Mann DL; Ewald GA; Moazami N
    Ann Thorac Surg; 2010 Oct; 90(4):1270-7. PubMed ID: 20868826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
    Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
    Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.